NUVISAN The Science CRO
Matthias Bader started their work experience in 2010 as a Doktorand at Technische Universität München, where they worked until 2012. Matthias then moved on to work as a Wissenschaftlicher Mitarbeiter at Lehrstuhl für Lebensmittelchemie und molekulare Sensorik from an unknown start date until August 2017. In 2017, they joined Nuvisan as Lab Head Biotransformation & MetID, DMPK, and later became the Head of Biotransformation in March 2023.
Matthias Bader completed their education from 2005 to 2009 at the Technical University of Munich. During this period, they obtained a 1. Staatsexamen degree in Lebensmittelchemie (Food Chemistry).
This person is not in the org chart
NUVISAN The Science CRO
1 followers
Founded in Europe with more than 40 years of experience, NUVISAN is a fully integrated contract research and development, and manufacturing organization (CRO/CDMO) that offers unique, high-quality, and tailored integrated solutions along the drug discovery and development value chain. With more than 1.000 employees distributed over six locations in Germany and France including our drug discovery hub in Berlin as well as with local experts situated in Latin America, NUVISAN is pleased to offer the following portfolio of services: • Drug discovery & research - Discovery pharmacology - Discovery bioscience - Screening - Life science chemistry - Translation research - Digital life science - Toxicology - DMPK • Non-clinical studies • Pharmaceutical analysis • Topical formulation development • Chemical development with GMP manufacturing (3-10kg) • Bioanalytical labs • GMP manufacturing (up to 50Kg) • Clinical trial supplies • Phase 1 and 2 clinical studies and beyond Our services can be provided as stand-alone or integrated solutions and can be customized to your project. Email us at hello@nuvisan.com for more.